2019
DOI: 10.1542/neo.20-4-e189
|View full text |Cite
|
Sign up to set email alerts
|

Prevention of Bronchopulmonary Dysplasia: A Summary of Evidence-Based Strategies

Abstract: Education Gap To decrease rates of bronchopulmonary dysplasia among extremely preterm infants, clinicians must implement multiple evidence-based strategies that target disease prevention. Less invasive surfactant administration is an emerging therapy that may help prevent bronchopulmonary dysplasia.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
24
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 26 publications
(26 citation statements)
references
References 102 publications
1
24
0
1
Order By: Relevance
“…39 Antenatal steroids have not, however, been shown to reduce the risk for BPD in randomized controlled trials (RCTs) (RR 0.86, 95% CI 0.42-1.79) or larger observational studies. [39][40][41]…”
Section: Prevention Prenatal Steroidsmentioning
confidence: 99%
See 4 more Smart Citations
“…39 Antenatal steroids have not, however, been shown to reduce the risk for BPD in randomized controlled trials (RCTs) (RR 0.86, 95% CI 0.42-1.79) or larger observational studies. [39][40][41]…”
Section: Prevention Prenatal Steroidsmentioning
confidence: 99%
“…However, no studies have been published to date to definitively suggest that its use reduces the incidence of BPD. 40,55 Based on the evidence discussed the American Academy of Pediatrics (AAP) Committee on Fetus and Newborn made the recommendation to use CPAP immediately after birth with selective administration of surfactant. 56 They also stated that if the infant is likely to require a ventilator for respiratory support that "early administration of surfactant with rapid extubation is preferable to prolonged ventilation.…”
Section: Noninvasive Ventilationmentioning
confidence: 99%
See 3 more Smart Citations